CRP and hepatocellular carcinoma: Various investigations have shown that hepatic function is associated with prognosis in patients treated with systemic therapy, however neo‐GPS which is a combination of ALBI grade and CRP, an inflammatory marker related to the progression of cancer, is thought to have the utility in comprehensively monitoring the clinical course of HCC.